LUNA Beauty Retatrutide 15mg

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, made up of 39 amino acids, designed to hit three key levers in metabolic regulation. This triple action results in:

• Appetite suppression through GLP-1 pathways, although milder than Tirzepatide
• Improved insulin sensitivity, lipid metabolism, and nutrient partitioning via GIP
• Increased energy expenditure and fat breakdown through glucagon receptor activation
• Greater resting metabolic rate compared to previous weight loss peptides
• Potential for more lean mass preservation during fat loss phases
• Deeper impact on stubborn visceral fat stores due to glucagon-driven thermogenesis
• Early studies show it may outperform both Semaglutide and Tirzepatide in total bodyweight reduction Together, targeting these three areas delivers a highly aggressive metabolic shift, reducing food intake while increasing the body’s drive to burn fat as fuel.

Therapeutic Applications

• Extreme fat loss for advanced cases or those resistant to dual agonist therapy
• Appetite suppression and increased energy expenditure for improved energy balance
• Improved body composition in metabolically suppressed or insulin-resistant individuals
• Potential benefits in non-alcoholic fatty liver, visceral adiposity, and pre-diabetes

Side Effects

• Nausea, fullness, early satiety
• GI distress more common at higher doses than other GLP-1 compounds
• Constipation or slowed digestion if hydration or fibre intake is poor
• Low energy or “flatness” due to suppressed caloric intake
• Difficulty eating enough to fuel training without strategic planning
• Increased risk of lean mass loss if combined with aggressive dieting and no resistance training

Use Cases

• Advanced body recomposition: Useful when previous GLP-1 or dual agonist therapies have plateaued or are no longer producing meaningful fat loss or when a more aggressive approach is required
• Aggressive metabolic intervention: Suitable for individuals with severe insulin resistance, fatty liver, or visceral adiposity who need rapid metabolic reversal
• Substrate shift promotion: Encourages fat oxidation over carbohydrate reliance, making it ideal for recomposition or maintenance phases after cutting
• Appetite and reward decoupling: Strong modulation of hunger cues and food reward systems, allowing for a mental reset in individuals with binge/restrict cycles
• Post-bulk or rebound correction: Helps athletes who struggle with hunger and overfeeding during post-competition phases return to baseline without harsh restriction